Are patients who have undergone splenectomy at increased risk for infection with Streptococcus pneumoniae?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Streptococcus pneumoniae is the Most Common and Dangerous Infection Risk After Splenectomy

Patients who have undergone splenectomy are at dramatically increased lifelong risk for overwhelming infection with Streptococcus pneumoniae, which represents the most common cause of post-splenectomy sepsis and carries significant mortality. 1

Understanding the Risk Profile

The spleen plays a critical role in clearing encapsulated bacteria, particularly S. pneumoniae. Without splenic function, patients lose this protective mechanism and face:

  • Lifelong risk: While most infections occur within the first 2 years post-splenectomy, up to one-third manifest at least 5 years later, with cases reported more than 20 years after surgery 1
  • Age-dependent severity: Children under 5 years (especially infants) have infection rates exceeding 10%, compared to <1% in adults 1
  • High mortality: Overwhelming post-splenectomy infection (OPSI) due to pneumococcus is frequently fatal, with rapid progression to septic shock, purpura fulminans, and multi-organ failure within hours 2, 3

Recent case reports demonstrate the catastrophic nature of pneumococcal OPSI, including a 39-year-old man who required amputation of all four limbs despite aggressive treatment 3, and two mothers who died within 2-17 hours of presentation despite intensive care 2.

Critical Management Algorithm

1. Immediate Post-Splenectomy Vaccination (Ideally 2 weeks pre-op if elective)

  • Administer 23-valent pneumococcal polysaccharide vaccine (PPSV23) - covers 23 serotypes and is >90% effective in healthy adults under 55 1
  • Consider protein-conjugate vaccines (PCV13/PCV15/PCV20) as they may provide better immune response in some patients who fail to respond to polysaccharide vaccines 4
  • Reimmunization every 5-10 years is essential, though children may need reimmunization as early as 2-3 years after initial dose 1

2. Lifelong Antibiotic Prophylaxis

All post-splenectomy patients should receive lifelong prophylactic antibiotics, with particular emphasis on the first 2 years: 1

  • First-line: Phenoxymethylpenicillin (penicillin V) daily
  • Penicillin allergy: Erythromycin as alternative
  • Patients should maintain a home supply of amoxicillin to start immediately at first sign of infection

3. Patient Education Essentials

Patients must understand:

  • Any fever requires immediate medical attention - this is potentially life-saving information 1
  • Carry medical alert card/information about splenectomy status at all times
  • Seek immediate care for animal bites (particularly susceptible to Capnocytophaga canimorsus) - requires 5-day co-amoxiclav course 1

Important Caveats and Pitfalls

Vaccination Does Not Guarantee Protection

Multiple recent cases demonstrate OPSI can occur despite appropriate vaccination 5, 6, 3:

  • A patient developed recurrent pneumococcal OPSI 8 years after initial infection despite PPSV23 vaccination 5
  • A 62-year-old woman developed OPSI just 1 year post-splenectomy despite immediate post-operative vaccination 6

Why vaccination fails:

  • Non-vaccine serotypes cause disease (serotype 34 and 23A in recent cases are not covered by available vaccines) 5, 3
  • Some individuals have genetically regulated failure to produce IgG antibodies to polysaccharide antigens 4
  • Antibody levels decline faster than expected in asplenic patients 1

Antibiotic Resistance is Rising

  • 46% of pneumococcal isolates in asplenic children were penicillin-nonsusceptible, and 19% were ceftriaxone-nonsusceptible 7
  • Post-vaccine serotype replacement has led to expansion of multidrug-resistant lineages (serotypes 15A, 15C, 35B) 8
  • However, no association was found between antimicrobial resistance and mortality in the pediatric study 7

High-Risk Presentations Requiring Aggressive Management

Recognize these red flags for fulminant OPSI:

  • Fever with petechiae or purpura 2, 3
  • Rapid progression to shock (within hours) 2
  • Disseminated intravascular coagulation 2, 7
  • Meningitis carries particularly high mortality - 5 of 6 deaths in one pediatric series had meningitis 7

Special Populations

Pregnant and postpartum women who have undergone splenectomy warrant particular attention, as two fatal cases occurred in mothers within the first year after delivery 2. Routine pneumococcal vaccination should be confirmed in prenatal care, and thorough medical interviews should screen for splenectomy or hyposplenism.

Children with congenital asplenia develop infections at much younger ages (median 12.5 months) compared to surgical splenectomy (median 69 months), and 75% of serotypes causing disease in asplenic children were included in conjugate vaccines, though 19% were caused by non-vaccine serotypes 7.

References

Research

Fatal overwhelming postsplenectomy infection caused by Streptococcus pneumoniae in mothers within 1 year after delivery: case report.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013

Research

Purpura fulminans caused by Streptococcus pneumoniae serotype 23A in a young post-splenectomy man: A case report.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2025

Research

Recurrent pneumococcal OPSI after splenectomy: The need for optimized vaccination and prophylaxis.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2025

Research

Invasive pneumococcal infections in children with asplenia.

The Pediatric infectious disease journal, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.